Why Baxter International Stock Was Tumbling Today

Sprawling medical devices and technology company Baxter International (NYSE: BAX) looked like it needed some medicine and a little rest on Thursday. The company's shares were down 17% in mid-session trading, on the back of an earnings report that many investors found lackluster. Baxter's fourth quarter of 2025 saw total sales rise 8% year over year to $2.97 billion. The company's net income from continuing operations not in accordance with generally accepted accounting principles (GAAP), however, slumped by 24% to $225 million ($0.44 per share). Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool